Cardiology - Case Reports
March 20, 2020
Vol. 90 No. 1 (2020)
Edoxaban in elderly patient with morbid obesity and atrial fibrillation: the role of plasma levels evaluation for selecting the appropriate dose
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1407
Views
852
Downloads
Authors
We present the case of a 80-year-old man with atrial fibrillation, morbid obesity (weight 123 kg, height 167 cm, BMI 44.1), high clearance of creatinine and pharmacological polytherapy, in which the serial determinations of edoxaban plasma levels help us to choose the appropriate dose.
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
“Edoxaban in Elderly Patient With Morbid Obesity and Atrial Fibrillation: The Role of Plasma Levels Evaluation for Selecting the Appropriate Dose”. 2020. Monaldi Archives for Chest Disease 90 (1). https://doi.org/10.4081/monaldi.2020.1224.